Equifax Inc

EFX is in a Stage 4 decline following a decisive support failure, with the medium-term bias firmly bearish. Price remains below the declining 9/20/50 EMAs and 200-day SMA, rejecting rallies from the 176–180 zone. Short-term price action continues lower with no oversold exhaustion despite RSI below 30. Sell-side engagement is advised on rallies into the established resistance cluster.

• ↑Q2 2026 revenue of $1.7B (+11% YoY) and EPS of $2.25 (+13%)
• ↑AI integration targeting $150M in savings by 2028 to boost margins
• ↓High rates and geopolitical tensions dent mortgage volumes and revenues